iStent inject W represents the next generation of Glaukos trabecular micro-bypass technology, which has been proven safe and effective in over one million eyes worldwide.
The gold standard in minimally-invasive glaucoma surgery (MIGS), iStent inject W continues the legacy of excellence set throughout 20 years of iStent devices. Glaukos states that it is backed by the most robust, diverse, and longest-term body of clinical evidence for any MIGS procedure available today, driven through clinical rigour and integrity.
iStent inject W is designed to reduce intraocular pressure by bypassing the primary source of resistance to improve aqueous outflow through the conventional pathway. It is indicated for the treatment of mild-to-moderate open angle glaucoma in patients undergoing cataract surgery or as a standalone procedure.